Discovery and development of calcium channel blockers

T Godfraind - Frontiers in pharmacology, 2017 - frontiersin.org
In the mid 1960s, experimental work on molecules under screening as coronary dilators
allowed the discovery of the mechanism of calcium entry blockade by drugs later named …

Hypertension and prohypertensive antineoplastic therapies in cancer patients

DCH Van Dorst, SJH Dobbin, KB Neves… - Circulation …, 2021 - Am Heart Assoc
The development of a wide range of novel antineoplastic therapies has improved the
prognosis for patients with a wide range of malignancies, which has increased the number …

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American …

SD Fihn, JM Gardin, J Abrams, K Berra… - Journal of the American …, 2012 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted as the document was compiled through …

[HTML][HTML] Role of iron metabolism in heart failure: From iron deficiency to iron overload

H Zhang, P Zhabyeyev, S Wang, GY Oudit - Biochimica et Biophysica Acta …, 2019 - Elsevier
Iron metabolism is a balancing act, and biological systems have evolved exquisite
regulatory mechanisms to maintain iron homeostasis. Iron metabolism disorders are …

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High …

C Rosendorff, HR Black, CP Cannon, BJ Gersh… - Circulation, 2007 - Am Heart Assoc
(CAD). Hypertension is a major independent risk factor for the development of CAD, stroke,
and renal failure. The optimal choice of antihypertensive agents remains controversial, and …

L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

GY Oudit, H Sun, MG Trivieri, SE Koch, F Dawood… - Nature medicine, 2003 - nature.com
Under conditions of iron overload, which are now reaching epidemic proportions worldwide,
iron-overload cardiomyopathy is the most important prognostic factor in patient survival. We …

[HTML][HTML] Calcium channel blockers

WJ Elliott, CVS Ram - The Journal of Clinical Hypertension, 2011 - ncbi.nlm.nih.gov
Key Points and Practical Recommendations• Calcium channel blockers, which dilate
arteries by reducing calcium flux into cells, effectively lower blood pressure, especially in …

Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment

CJ Murphy, GY Oudit - Journal of cardiac failure, 2010 - Elsevier
BACKGROUND: The prevalence of primary (hereditary) hemochromatosis and secondary
iron overload (hemosiderosis) is reaching epidemic levels worldwide. Iron-overload leads to …

Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas

CE Mogensen - The kidney and hypertension in diabetes mellitus, 2004 - taylorfrancis.com
Carl Erik Mogensen Medical Department M, Diabetes and Endocrinology, Aarhus
Kommunehospital, Aarhus University Hospital, Aarhus, Denmark (Modified from …

Biomimetic nanoparticle technology for cardiovascular disease detection and treatment

JH Park, D Dehaini, J Zhou, M Holay, RH Fang… - Nanoscale …, 2020 - pubs.rsc.org
Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …